Quick Answer
Caris Life Sciences, Inc. reported Net Income Loss of -$68.09 million for the year ending 2025.
- Caris Life Sciences, Inc. showed an increase of +75.8% in Net Income Loss from 2024 to 2025.
- This data is from Caris Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Caris Life Sciences, Inc.'s Net Income Loss has grown by 80.1%.
- Historical annual values: Fiscal year 2025: -$68.09 million | Fiscal year 2024: -$281.89 million | Fiscal year 2023: -$341.42 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: